Dear Valued Stakeholder

We are excited to announce a significant milestone in our company’s evolution. Hybrigenics, a leading bio-science company, has undergone a rebrand and is now officially known as ATON. This strategic decision reflects our newly evolved vision as we embark on a transformative journey, turning research into life-changing medicines, for the good of patients, medicine and society as a whole.

At ATON, our primary goal is to drive a fundamental shift in the way treatments are provided, with a strong emphasis on personalisation. We firmly believe that every patient deserves treatments that are tailored to their unique biology, leading to more effective and safer outcomes. We are committed to create, support and energise next-generation life science companies, to provide more effective, safer treatments for patients. This patient-centric approach lies at the heart of our new vision and serves as our guiding principle in all our endeavours.

We invite you to come on this exciting journey with us as we transition to ATON. Our focus on personalised medicine aligns with your needs as valued customers, and we are committed to delivering the highest quality products and services tailored to your requirements. We are confident that our rebrand will bring new opportunities for collaboration and drive advancements that positively impact patient care.

OUR PURPOSE
OUR PURPOSE

Our driving purpose is to advance therapies for the good of patients, medicine and society.

Our cutting-edge companies work in synergy, to accelerate and advance testing and development of effective medicines. Our aim is to give every patient access to tomorrow’s therapies: the right treatment, to the right person, at the right time.

Learn more
Image
Image
OUR PLATFORMS

Game-changing life science platforms

Our platforms are driving a fundamental shift to provide opportunities for more personalization and precision products and services. Diverse platforms, each with unique world-leading technologies and a team of experts united by one desire, to advance and accelerate medical discoveries for the good of patients, medicine, and society.  Aton’s platforms bring significant expertise to guide and support life science businesses in achieving their goals with greater efficiency.
Preclinical & Clinical Services
Preclinical & Clinical Services
Preclinical & Clinical Services
We accelerate and secure the entire drug development process with a patient-centred approach, optimizing our customers' time and resources so...
Learn more
Monoclonal Antibodies Production
Monoclonal Antibodies Production
Monoclonal Antibodies Production
Bcell Design is a leading provider of leading-edge monoclonal antibodies with human Fc for companies specializing in in vitro diagnostic...
Learn more
Medical Device Production
Medical Device Production
Medical Device Production
Stemcis has designed and manufactured all-in-one, sterile, and single-use surgical kits to revolutionize the field of fat transfer surgery.
Learn more
Laboratory Equipment Production
Laboratory Equipment Production
Laboratory Equipment Production
Its accuracy and sensitivity surpass traditional methods, facilitating real-time analysis and personalized medicine. Unravel the complexities of molecular behaviors and...
Learn more
Human Tissue Provision
Human Tissue Provision
Human Tissue Provision
We ensure that all clinical tissues are procured through rigorous ethical guidelines, with informed consent obtained from donors.
Learn more
INVESTORS

Accelerating the pursuit of tomorrow’s therapies

Turn perspectives into reality. Turn present into future. Turn risk into opportunity. Turn investment into journey. Turn research into medicine. Turn to Aton.

Investor Center
NEWS & INSIGHTS

Get the latest Insights and News from the Aton team

Stemcis comes to the US to introduce its fat transfer kits 15th November 2023
Stemcis comes to the US to introduce its fat transfer kits
Read article
Medica fair trade 13th November 2023
Medica fair trade
Read article
Stemcis breaks all records at the Plastic Surgery Meeting in Austin (USA). 8th November 2023
Stemcis breaks all records at the Plastic Surgery Meeting in Austin (USA).
Read article
Plastic Surgery – The Meeting 27th October 2023
Plastic Surgery – The Meeting
Read article
Chat with Dr Pierre Eftekhari on Dr.GPCR Podcast 9th June 2023
Chat with Dr Pierre Eftekhari on Dr.GPCR Podcast
Read article
In conversation with Dr Pierre Eftekhari on Drug Discovery World Podcast 8th June 2023
In conversation with Dr Pierre Eftekhari on Drug Discovery World Podcast
Read article

Let’s talk!

Please leave your details and we’ll get back to you.

Get in touch
CTA Image
CTA Image